Study of parenteral antibiotics used in post operative fibroid uterus in the department of obstetrics and gynaecology
International Journal of Development Research
Study of parenteral antibiotics used in post operative fibroid uterus in the department of obstetrics and gynaecology
Received 12th May, 2017; Received in revised form 17th June, 2017; Accepted 20th July, 2017; Published online 30th August, 2017
Copyright ©2017, Suresh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background: Uterine fibroids, or leiomyoma, are tumors or growths made of smooth muscle cells and other tissue in the uterus wall. They are the most common non-cancerous tumors in women of childbearing age. It can cause painful symptoms and abnormal bleeding from the uterus. Fibroids are located in certain parts of the uterus, such as the uterine cavity, can also make it difficult for a woman to get pregnant or maintain a pregnancy.Antibiotics are the more widely used drugs to prevent surgical site infections in gynaecology surgeries even though there was evidence of complication. The large exposure of antibiotic leads to high profile resistance which paved the way to high health care cost, lack of resources. Objective: Study of parenteral antibiotics used in post operative fibroid uterus patients in the O&G department Material method: Prospective observation study, all the patients admitted in O&G ward in RMMCH during in 4 month study period from October 2016 to January 2017 who has compliance with inclusion and exclusion criteria. Results: The total number of 40 patients. Among the study population more patients with fibroid uterus were the under age group of 40-50 years. Mostly 35-50 years age women’s were affected in the fibroid uterus. The majority of the parenteral antibiotics mostly prescribed in the antibiotic is a broad spectrum of antibiotic. Among this METRONIDAZOLE < CEFOTAXIM < AMPICILIN < GENTAMICIN < CEFTRIAXONE was prescribed. The comparisons of the mono therapy and combination therapy. The most of the patients treat with combination therapy 36 patients in 90 percentages. The monotherapy were is 4 patients in 10 percentages.